{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:38:13Z","timestamp":1792633093464,"version":"4.5.0"},"reference-count":236,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,15]]},"DOI":"10.1086\/497143","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T18:56:58Z","timestamp":1129748218000},"page":"1373-1406","source":"Crossref","is-referenced-by-count":1224,"title":["Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections"],"prefix":"10.1093","volume":"41","author":[{"given":"Dennis L.","family":"Stevens","sequence":"first","affiliation":[{"name":"\u00a0Infectious Diseases Section, Veterans Affairs Medical Center, Boise, Idaho"},{"name":"\u00a0University of Washington School of Medicine, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Bisno","sequence":"additional","affiliation":[{"name":"\u00a0University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Chambers","sequence":"additional","affiliation":[{"name":"\u00a0Infectious Diseases, San Francisco General Hospital, San Francisco"},{"name":"\u00a0University of California\u2014San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Dale","family":"Everett","sequence":"additional","affiliation":[{"name":"\u00a0University of Missouri Health Science Center, University of Missouri, Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patchen","family":"Dellinger","sequence":"additional","affiliation":[{"name":"\u00a0Department of Surgery, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie J. C.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"\u00a0R. M. Alden Research Laboratory, Santa Monica"},{"name":"\u00a0University of California, Los Angeles School of Medicine, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherwood L.","family":"Gorbach","sequence":"additional","affiliation":[{"name":"\u00a0Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan V.","family":"Hirschmann","sequence":"additional","affiliation":[{"name":"\u00a0University of Washington School of Medicine, Seattle, Washington"},{"name":"\u00a0Seattle Veterans Affairs Medical Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"\u00a0University of Minnesota Medical School, Minneapolis, Minnesota"},{"name":"\u00a0Division of Epidemiology, University of Minnesota School of Public Health, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Montoya","sequence":"additional","affiliation":[{"name":"\u00a0Department of Medicine, Palo Alto, California"},{"name":"\u00a0Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Palo Alto, California"},{"name":"\u00a0Research Institute, Palo Alto Medical Foundation, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Wade","sequence":"additional","affiliation":[{"name":"\u00a0Division of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,11,15]]},"reference":[{"key":"2020110410211695100_ref1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","article-title":"The LRINEC (Laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections","volume":"32","author":"Wong","year":"2004","journal-title":"Crit Care Med"},{"key":"2020110410211695100_ref2","first-page":"81","article-title":"Antimicrobial resistance of Staphylococcus aureus from Kansas City children: what is the appropriate current therapy for pediatric staphylococcal infections [abstract 252]?","volume-title":"Proceedings and abstracts of the 42nd Annual Meeting of the Infectious Diseases Society of America (Boston)","author":"Thorell","year":"2004"},{"key":"2020110410211695100_ref3","first-page":"139","article-title":"Use of tetracyclines for infections caused by methicillin-resistant Staphylococcus aureus [abstract 516]","volume-title":"Proceedings and abstracts of the 42nd Annual Meeting of the Infectious Diseases Society of America (Boston)","author":"Ruhe","year":"2004"},{"key":"2020110410211695100_ref4","first-page":"102","article-title":"Erythromycin resistance among invasive group A streptococcal infections, United States, 1999\u20132001 [abstract 345]","volume-title":"Proceedings and abstracts of the 42nd Annual Meeting of the Infectious Diseases Society of America (Boston)","author":"Van Beneden","year":"2004"},{"key":"2020110410211695100_ref5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/jac\/dkg140","article-title":"Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital","volume":"51","author":"Yun","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2020110410211695100_ref6","first-page":"693","article-title":"Antimicrobial agents and related therapy","volume-title":"Red book 2003 report of the Committee on Infectious Diseases","author":"Committee on Infectious Diseases, American Academy of Pediatrics","year":"2003","edition":"6th ed."},{"key":"2020110410211695100_ref7","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref8","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1172\/JCI107108","article-title":"Natural history of impetigo. 1. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci","volume":"51","author":"Ferrieri","year":"1972","journal-title":"J Clin Invest"},{"key":"2020110410211695100_ref9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00007256-200232050-00003","article-title":"Dermatologic disorders of the athlete","volume":"32","author":"Adams","year":"2002","journal-title":"Sports Med"},{"key":"2020110410211695100_ref10","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1001\/jama.1987.03400210073028","article-title":"Group A beta-hemolytic streptococcal skin infections in a US meat-packing plant","volume":"258","author":"Fehrs","year":"1987","journal-title":"JAMA"},{"key":"2020110410211695100_ref11","first-page":"42","article-title":"Impetigo: etiology and therapy","volume":"22","author":"Hirschmann","year":"2002","journal-title":"Curr Clin Top Infect Dis"},{"key":"2020110410211695100_ref12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1525-1470.1994.tb00092.x","article-title":"Impetigo: an overview","volume":"11","author":"Darmstadt","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"2020110410211695100_ref13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archpedi.1990.02150360037015","article-title":"Impetigo: current etiology and comparison of penicillin, erythromycin, and cephalexin therapies","volume":"144","author":"Demidovich","year":"1990","journal-title":"Am J Dis Child"},{"key":"2020110410211695100_ref14","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI106358","article-title":"The influence of the site of infection on the immune response to group A streptococci","volume":"49","author":"Kaplan","year":"1970","journal-title":"J Clin Invest"},{"key":"2020110410211695100_ref15","first-page":"410","article-title":"Factors influencing serum antibody response in streptococcal pyoderma","volume":"81","author":"Bisno","year":"1973","journal-title":"J Lab Clin Med"},{"key":"2020110410211695100_ref16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1084\/jem.144.3.754","article-title":"Suppression of the anti-streptolysin O response by cholesterol and by lipid extracts of rabbit skin","volume":"144","author":"Kaplan","year":"1976","journal-title":"J Exp Med"},{"key":"2020110410211695100_ref17","first-page":"75","article-title":"Impetigo contagiosa","volume":"4","author":"Derrick","year":"1971","journal-title":"Am Fam Physician"},{"key":"2020110410211695100_ref18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/infdis\/129.4.429","article-title":"A controlled study of penicillin prophylaxis against streptococcal impetigo","volume":"129","author":"Ferrieri","year":"1974","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref19","first-page":"916","article-title":"Comparison of amoxicillin and clavulanic acid (augmentin) for the treatment of nonbullous impetigo","volume":"143","author":"Dagan","year":"1989","journal-title":"Am J Dis Child"},{"key":"2020110410211695100_ref20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1525-1470.1987.tb00776.x","article-title":"Impetigo: a reassessment of etiology and therapy","volume":"4","author":"Barton","year":"1987","journal-title":"Pediatr Dermatol"},{"key":"2020110410211695100_ref21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1525-1470.1989.tb01012.x","article-title":"Impetigo contagiosa III: comparative efficacy of oral erythromycin and topical mupirocin","volume":"6","author":"Barton","year":"1989","journal-title":"Pediatr Dermatol"},{"key":"2020110410211695100_ref22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0022-3476(05)83352-9","article-title":"Comparison of mupirocin and erythromycin in the treatment of impetigo","volume":"117","author":"Britton","year":"1990","journal-title":"J Pediatr"},{"key":"2020110410211695100_ref23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/124.2.229","article-title":"Does antimicrobial therapy of streptococcal pharyngitis or pyoderma alter the risk of glomerulonephritis?","volume":"124","author":"Weinstein","year":"1971","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/0003-4819-87-2-145","article-title":"Cutaneous abscesses: anaerobic and aerobic bacteriology and outpatient management","volume":"87","author":"Meislin","year":"1977","journal-title":"Ann Intern Med"},{"key":"2020110410211695100_ref25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/bjs.1800680719","article-title":"Aerobic and anaerobic bacteriology of subcutaneous abscesses","volume":"68","author":"Ghoneim","year":"1981","journal-title":"Br J Surg"},{"key":"2020110410211695100_ref26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archsurg.1990.01410230039007","article-title":"Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses","volume":"125","author":"Brook","year":"1990","journal-title":"Arch Surg"},{"key":"2020110410211695100_ref27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/bmj.2.6181.5","article-title":"Anaerobic axillary abscess","volume":"2","author":"Leach","year":"1979","journal-title":"Br Med J"},{"key":"2020110410211695100_ref28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/bjs.1800691215","article-title":"The aetiology of scrotal sepsis","volume":"69","author":"Whitehead","year":"1982","journal-title":"Br J Surg"},{"key":"2020110410211695100_ref29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/infdis\/162.3.695","article-title":"The nonpuerperal breast infection: aerobic and anaerobic microbial recovery from acute and chronic disease","volume":"162","author":"Edmiston","year":"1990","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bjs.1800690319","article-title":"The aetiology of perirectal sepsis","volume":"69","author":"Whitehead","year":"1982","journal-title":"Br J Surg"},{"key":"2020110410211695100_ref31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.134.1.49","article-title":"Bacteriology of inflamed and uninflamed epidermal inclusion cysts","volume":"134","author":"Diven","year":"1998","journal-title":"Arch Dermatol"},{"key":"2020110410211695100_ref32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0196-0644(85)80727-7","article-title":"Treatment of cutaneous abscess: a double-blind clinical study","volume":"14","author":"Llera","year":"1985","journal-title":"Ann Emerg Med"},{"key":"2020110410211695100_ref33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/bjs.1800640410","article-title":"The treatment of acute superficial abscesses: a prospective clinical trial","volume":"64","author":"Macfie","year":"1977","journal-title":"Br J Surg"},{"key":"2020110410211695100_ref34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/oxfordjournals.aje.a114486","article-title":"An outbreak of staphylococcal skin infections among river rafting guides","volume":"124","author":"Decker","year":"1986","journal-title":"Am J Epidemiol"},{"key":"2020110410211695100_ref35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/036354658901700618","article-title":"An outbreak of furunculosis among high school athletes","volume":"17","author":"Sosin","year":"1989","journal-title":"Am J Sports Med"},{"key":"2020110410211695100_ref36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/00365548809032475","article-title":"Recurrent staphylococcal furunculosis in families","volume":"20","author":"Zimakoff","year":"1988","journal-title":"Scand J Infect Dis"},{"key":"2020110410211695100_ref37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/inf.1981.13.issue-2.07","article-title":"Recurrent staphylococcal furunculosis: bacteriological findings and epidemiology in 100 cases","volume":"13","author":"Hedstrom","year":"1981","journal-title":"Scand J Infect Dis"},{"key":"2020110410211695100_ref38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archinte.1996.00040041109010","article-title":"A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection","volume":"156","author":"Raz","year":"1996","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01971270","article-title":"Immediate and long-term efficacy of systemic antibiotics for eradicating nasal colonization with Staphylococcus aureus","volume":"11","author":"Lipsky","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020110410211695100_ref40","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1001\/jama.1988.03410180090035","article-title":"Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy","volume":"260","author":"Klempner","year":"1988","journal-title":"JAMA"},{"key":"2020110410211695100_ref41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM199601253340407","article-title":"Streptococcal infections in skin and soft tissues","volume":"334","author":"Bisno","year":"1996","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-4362.1990.tb04833.x","article-title":"Erysipelas","volume":"29","author":"Chartier","year":"1990","journal-title":"Int J Dermatol"},{"key":"2020110410211695100_ref43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1365-4362.1996.tb02971.x","article-title":"Erysipelas: an update","volume":"35","author":"Chartier","year":"1996","journal-title":"Int J Dermatol"},{"key":"2020110410211695100_ref44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMcp031807","article-title":"Clinical practice: cellulitis","volume":"350","author":"Swartz","year":"2004","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.1992.tb08048.x","article-title":"Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study","volume":"127","author":"Bernard","year":"1992","journal-title":"Br J Dermatol"},{"key":"2020110410211695100_ref46","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa013169","article-title":"Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref47","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JCM.37.6.1727-1731.1999","article-title":"Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California","volume":"37","author":"York","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2020110410211695100_ref48","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.318.7198.1591","article-title":"Risk factors for erysipelas of the leg (cellulitis): case-control study","volume":"318","author":"Dupuy","year":"1999","journal-title":"BMJ"},{"key":"2020110410211695100_ref49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01650207","article-title":"Incidence of erysipelas following venectomy for coronary artery bypass surgery","volume":"15","author":"Dan","year":"1987","journal-title":"Infection"},{"key":"2020110410211695100_ref50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-97-4-493","article-title":"Recurrent cellulitis after saphenous venectomy for coronary bypass surgery","volume":"97","author":"Baddour","year":"1982","journal-title":"Ann Intern Med"},{"key":"2020110410211695100_ref51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9343(92)90583-W","article-title":"Cellulitis after axillary lymph node dissection for carcinoma of the breast","volume":"93","author":"Simon","year":"1992","journal-title":"Am J Med"},{"key":"2020110410211695100_ref52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2796.1999.00404.x","article-title":"Breast cellulitis complicating breast conservation therapy","volume":"245","author":"Baddour","year":"1999","journal-title":"J Intern Med"},{"key":"2020110410211695100_ref53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0090-8258(88)90146-1","article-title":"Recurrent acute leg cellulitis in patients after radical vulvectomy","volume":"29","author":"Bouma","year":"1988","journal-title":"Gynecol Oncol"},{"key":"2020110410211695100_ref54","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1471-0528.1987.tb03728.x","article-title":"Recurrent acute leg cellulitis after hysterectomy with pelvic lymphadenectomy","volume":"94","author":"Dankert","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"2020110410211695100_ref55","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/313525","article-title":"Cost-effectiveness of blood cultures for adult patients with cellulitis","volume":"29","author":"Perl","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref56","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1001\/archinte.1988.00380110091019","article-title":"Influence of underlying disease process on the utility of cellulitis needle aspirates","volume":"148","author":"Kielhofner","year":"1988","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archinte.1986.00360140113016","article-title":"Microbiologic evaluation of cutaneous cellulitis in adults","volume":"146","author":"Hook","year":"1986","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref58","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/archinte.1990.00390200091017","article-title":"The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults","volume":"150","author":"Sachs","year":"1990","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2133.1985.tb15264.x","article-title":"The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas","volume":"112","author":"Leppard","year":"1985","journal-title":"Br J Dermatol"},{"key":"2020110410211695100_ref60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/00365548909037882","article-title":"The etiology of bacterial cellulitis as determined by fine-needle aspiration","volume":"21","author":"Sigurdsson","year":"1989","journal-title":"Scand J Infect Dis"},{"key":"2020110410211695100_ref61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/JCM.26.3.401-404.1988","article-title":"Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults","volume":"26","author":"Newell","year":"1988","journal-title":"J Clin Microbiol"},{"key":"2020110410211695100_ref62","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archderm.1996.03890310134030","article-title":"Value of fine-needle aspiration in infectious cellulitis","volume":"132","author":"Lebre","year":"1996","journal-title":"Arch Dermatol"},{"key":"2020110410211695100_ref63","first-page":"45","article-title":"Microbiology of adult cellulitis","volume":"26","author":"Lutomski","year":"1988","journal-title":"J Fam Pract"},{"key":"2020110410211695100_ref64","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archinte.1989.00390020039008","article-title":"Quantitative cultures of biopsy specimens from cutaneous cellulitis","volume":"149","author":"Duvanel","year":"1989","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref65","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/clinids\/23.5.1091","article-title":"Erysipelas: clinical and bacteriologic spectrum and serological aspects","volume":"23","author":"Eriksson","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref66","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archderm.1987.01660280070025","article-title":"Early detection of streptococcal group antigens in skin samples by latex particle agglutination","volume":"123","author":"Bernard","year":"1987","journal-title":"Arch Dermatol"},{"key":"2020110410211695100_ref67","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archderm.1989.01670180051004","article-title":"Streptococcal cause of erysipelas and cellulitis in adults: a microbiologic study using a direct immunofluorescence technique","volume":"125","author":"Bernard","year":"1989","journal-title":"Arch Dermatol"},{"key":"2020110410211695100_ref68","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1984.03340320035023","article-title":"Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs","volume":"251","author":"Baddour","year":"1984","journal-title":"JAMA"},{"key":"2020110410211695100_ref69","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/clinids\/23.5.1162","article-title":"Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples","volume":"23","author":"Semel","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref70","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/313467","article-title":"Anal colonization of group G \u03b2-hemolytic streptococci in relapsing erysipelas of the lower extremity","volume":"29","author":"Eriksson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref71","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/clinids\/20.3.564","article-title":"Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia","volume":"20","author":"Burman","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref72","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0190-9622(93)70085-8","article-title":"The clinical spectrum of lipodermatosclerosis","volume":"28","author":"Kirsner","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"2020110410211695100_ref73","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01645222","article-title":"The course, costs, and complications of oral versus intravenous penicillin therapy of erysipelas","volume":"12","author":"Jorup-Ronstrom","year":"1984","journal-title":"Infection"},{"key":"2020110410211695100_ref74","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref75","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/00365549709011834","article-title":"Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study","volume":"29","author":"Bergkvist","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"2020110410211695100_ref76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/003655498750003708","article-title":"Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up","volume":"30","author":"Bergkvist","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"2020110410211695100_ref77","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.1966.03100100123046","article-title":"Prophylaxis of recurrent lymphangitis complicating lymphedema","volume":"195","author":"Babb","year":"1966","journal-title":"JAMA"},{"key":"2020110410211695100_ref78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0163-4453(91)90898-3","article-title":"Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections","volume":"22","author":"Kremer","year":"1991","journal-title":"J Infect"},{"key":"2020110410211695100_ref79","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01728920","article-title":"Antibiotic prophylaxis in recurrent erysipelas","volume":"21","author":"Sjoblom","year":"1993","journal-title":"Infection"},{"key":"2020110410211695100_ref80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/513752","article-title":"Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs","volume":"25","author":"Wang","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref81","first-page":"2227","article-title":"Sodium selenite as prophylaxis against erysipelas in secondary lymphedema","volume":"18","author":"Kasseroller","year":"1998","journal-title":"Anticancer Res"},{"key":"2020110410211695100_ref82","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.286.10.1201","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community","volume":"286","author":"Groom","year":"2001","journal-title":"JAMA"},{"key":"2020110410211695100_ref83","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jama.279.8.593","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk","volume":"279","author":"Herold","year":"1998","journal-title":"JAMA"},{"key":"2020110410211695100_ref84","first-page":"88","article-title":"Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections\u2014Los Angeles County, California, 2002\u20132003","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020110410211695100_ref85","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/AAC.46.4.1147-1152.2002","article-title":"Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains","volume":"46","author":"Ma","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410211695100_ref86","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/JCM.40.11.4289-4294.2002","article-title":"Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community","volume":"40","author":"Okuma","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2020110410211695100_ref87","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/342576","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin","volume":"35","author":"Dufour","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref88","first-page":"992","article-title":"Methicillin-resistant Staphylococcus aureus infections in correctional facilities\u2014Georgia, California, and Texas, 2001\u20132003","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020110410211695100_ref89","first-page":"793","article-title":"Methicillin-resistant Staphylococcus aureus infections among competitive sports participants\u2014Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000\u20132003","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020110410211695100_ref90","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","article-title":"Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections","volume":"44","author":"Stevens","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410211695100_ref91","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Linezolid MRSA Study Group","volume":"34","author":"Stevens","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref92","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"2020110410211695100_ref93","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0039-6109(16)44440-3","article-title":"Necrotizing soft-tissue infections","volume":"68","author":"Ahrenholz","year":"1988","journal-title":"Surg Clin North Am"},{"key":"2020110410211695100_ref94","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0891-5520(20)30470-0","article-title":"Necrotizing soft-tissue infections","volume":"6","author":"Lewis","year":"1992","journal-title":"Infect Dis Clin North Am"},{"key":"2020110410211695100_ref95","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00000658-197012000-00005","article-title":"Necrotizing fasciitis","volume":"172","author":"Rea","year":"1970","journal-title":"Ann Surg"},{"key":"2020110410211695100_ref96","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9610(77)90283-5","article-title":"Bacteriology of necrotizing fasciitis","volume":"134","author":"Giuliano","year":"1977","journal-title":"Am J Surg"},{"key":"2020110410211695100_ref97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: severe group A streptococcal infections associated with a toxic shock-like syndrome","volume":"321","author":"Stevens","year":"1989","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref98","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(94)90629-7","article-title":"Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features","volume":"344","author":"Chelsom","year":"1994","journal-title":"Lancet"},{"key":"2020110410211695100_ref99","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410211695100_ref100","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/01.SMJ.0000051060.95210.9A","article-title":"Invasive group A streptococcal infections in Florida","volume":"96","author":"Mulla","year":"2003","journal-title":"South Med J"},{"key":"2020110410211695100_ref101","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/376652","article-title":"Dilemmas in the treatment of invasive Streptococcus pyogenes infections","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref102","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome: a comparative observational study","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref103","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0163-4453(94)90530-4","article-title":"Tropical pyomyositis","volume":"29","author":"Sissolak","year":"1994","journal-title":"J Infect"},{"key":"2020110410211695100_ref105","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0039-6109(16)46485-6","article-title":"Fournier's gangrene","volume":"74","author":"Laucks","year":"1994","journal-title":"Surg Clin North Am"},{"key":"2020110410211695100_ref106","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1365-2168.2000.01497.x","article-title":"Fournier's gangrene: a review of 1726 cases","volume":"87","author":"Eke","year":"2000","journal-title":"Br J Surg"},{"key":"2020110410211695100_ref107","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.1971.03190060046011","article-title":"Prevention and treatment of gas gangrene","volume":"217","author":"Altemeier","year":"1971","journal-title":"JAMA"},{"key":"2020110410211695100_ref108","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/AAC.31.2.312","article-title":"Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens","volume":"31","author":"Stevens","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410211695100_ref109","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/155.2.220","article-title":"Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens","volume":"155","author":"Stevens","year":"1987","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/clinids\/17.2.231","article-title":"Evaluation of hyperbaric oxygen therapy for treatment of experimental Clostridium perfringens infection","volume":"17","author":"Stevens","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM199901143400202","article-title":"Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group","volume":"340","author":"Talan","year":"1999","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref112","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/jcm.8.6.667-672.1978","article-title":"Bacteriology of human and animal bite wounds","volume":"8","author":"Goldstein","year":"1978","journal-title":"J Clin Microbiol"},{"key":"2020110410211695100_ref113","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1099\/00222615-47-2-95","article-title":"New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds","volume":"47","author":"Goldstein","year":"1998","journal-title":"J Med Microbiol"},{"key":"2020110410211695100_ref114","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-4362.1987.tb00544.x","article-title":"Outpatient therapy of bite wounds: demographic data, bacteriology, and a prospective, randomized trial of amoxicillin\/clavulanic acid versus penicillin +\/- dicloxacillin","volume":"26","author":"Goldstein","year":"1987","journal-title":"Int J Dermatol"},{"key":"2020110410211695100_ref115","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/379331","article-title":"Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments","volume":"37","author":"Talan","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref116","first-page":"522","article-title":"Transmission of HIV by human bite","volume":"2","year":"1987","journal-title":"Lancet"},{"key":"2020110410211695100_ref117","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(96)90838-7","article-title":"Transmission of HIV-1 by human bite","volume":"347","author":"Vidmar","year":"1996","journal-title":"Lancet"},{"key":"2020110410211695100_ref118","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0140-6736(90)92049-N","article-title":"Hepatitis C virus transmitted by human bite","volume":"336","author":"Dusheiko","year":"1990","journal-title":"Lancet"},{"key":"2020110410211695100_ref119","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(89)92876-6","article-title":"Horizontal transmission of hepatitis B virus","volume":"1","author":"Davis","year":"1989","journal-title":"Lancet"},{"key":"2020110410211695100_ref120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007435-198101000-00008","article-title":"Primary syphilis following a human bite","volume":"8","author":"Fiumara","year":"1981","journal-title":"Sex Transm Dis"},{"key":"2020110410211695100_ref121","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"2020110410211695100_ref122","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref123","first-page":"909","article-title":"Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020110410211695100_ref124","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00006454-199806000-00002","article-title":"Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease","volume":"17","author":"Bass","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410211695100_ref125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/CMR.2.4.354","article-title":"Erysipelothrix rhusiopathiae: an occupational pathogen","volume":"2","author":"Reboli","year":"1989","journal-title":"Clin Microbiol Rev"},{"key":"2020110410211695100_ref126","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1128\/AAC.34.10.2038","article-title":"Antimicrobial susceptibilities of Erysipelothrix rhusiopathiae","volume":"34","author":"Venditti","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410211695100_ref127","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1056\/NEJM200107263450404","article-title":"Glanders in a military research microbiologist","volume":"345","author":"Srinivasan","year":"2001","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"2020110410211695100_ref129","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"2020110410211695100_ref130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/clinids\/19.1.42","article-title":"Streptomycin and alternative agents for the treatment of tularemia: review of the literature","volume":"19","author":"Enderlin","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref131","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00006454-200005000-00011","article-title":"Ciprofloxacin for treatment of tularemia in children","volume":"19","author":"Johansson","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410211695100_ref132","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/313946","article-title":"Treatment of tularemia with ciprofloxacin","volume":"31","author":"Chocarro","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref133","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/322601","article-title":"Tularemia epidemic in northwestern Spain: clinical description and therapeutic response","volume":"33","author":"Perez-Castrillon","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref134","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJM199102073240604","article-title":"Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice study I","volume":"324","author":"Brennan","year":"1991","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999: Hospital Infection Control Practices Advisory Committee","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 2","key":"2020110410211695100_ref136","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/321860","article-title":"Surgical site infection (SSI) rates in the United States, 1992\u20131998: the National Nosocomial Infections Surveillance System basic SSI risk index","volume":"33","author":"Gaynes","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref137","first-page":"903","article-title":"Approach to the patient with postoperative fever","volume-title":"Infectious diseases in medicine and surgery","author":"Dellinger","year":"1998"},{"key":"2020110410211695100_ref138","first-page":"161","article-title":"The effective period of preventive antibiotic action in experimental incisions and dermal lesions","volume":"50","author":"Burke","year":"1961","journal-title":"Surgery"},{"key":"2020110410211695100_ref139","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199201303260501","article-title":"The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection","volume":"326","author":"Classen","year":"1992","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref140","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00000658-197906000-00004","article-title":"Prophylactic and preventive antibiotic therapy: timing, duration and economics","volume":"189","author":"Stone","year":"1979","journal-title":"Ann Surg"},{"key":"2020110410211695100_ref141","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clinids\/18.3.422","article-title":"Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America","volume":"18","author":"Dellinger","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref142","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1086\/421095","article-title":"Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project","volume":"38","author":"Bratzler","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref143","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1445-2197.1998.tb04785.x","article-title":"Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review","volume":"68","author":"McDonald","year":"1998","journal-title":"Aust N Z J Surg"},{"key":"2020110410211695100_ref144","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.1982.03320350052030","article-title":"Toxic shock syndrome associated with surgical wound infections","volume":"247","author":"Bartlett","year":"1982","journal-title":"JAMA"},{"key":"2020110410211695100_ref145","first-page":"130","article-title":"Postoperative toxic shock syndrome","volume":"24","author":"Raab","year":"1995","journal-title":"Am J Orthop"},{"key":"2020110410211695100_ref146","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-4453(86)92118-3","article-title":"The value of adjuvant systemic antibiotic therapy in localised wound infections among hospital patients: a comparative study","volume":"13","author":"Huizinga","year":"1986","journal-title":"J Infect"},{"key":"2020110410211695100_ref147","volume-title":"Mandell, Douglas and Bennett's principles and practice of infectious diseases","author":"Mandell","year":"1995"},{"key":"2020110410211695100_ref148","volume-title":"Surgical infectious diseases","author":"Howard","year":"1988"},{"key":"2020110410211695100_ref149","volume-title":"Surgical infections","author":"Fry","year":"1995"},{"key":"2020110410211695100_ref150","volume-title":"Surgery: scientific principles and practice","author":"Greenfield","year":"1993"},{"key":"2020110410211695100_ref151","volume-title":"Textbook of surgery: the biologic basis of modern surgical practice","author":"Townsend","year":"2001"},{"key":"2020110410211695100_ref152","volume-title":"ACS surgery: principles and practice","author":"Wilmore","year":"2002"},{"key":"2020110410211695100_ref153","volume-title":"Infectious diseases","author":"Gorbach","year":"1998"},{"key":"2020110410211695100_ref154","first-page":"1221","article-title":"Nosocomial infection","volume-title":"ACS surgery: principles and practice","author":"Dellinger","year":"2002"},{"key":"2020110410211695100_ref155","first-page":"319","article-title":"Wound infections: epidemiology and clinical characteristics","volume-title":"Surgical infectious diseases","author":"Cruse","year":"1988"},{"key":"2020110410211695100_ref156","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0196-0644(97)70354-8","article-title":"Incision and drainage of cutaneous abscesses is not associated with bacteremia in afebrile adults","volume":"29","author":"Bobrow","year":"1997","journal-title":"Ann Emerg Med"},{"key":"2020110410211695100_ref157","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0196-0644(86)80577-7","article-title":"Pathogen identification of abscesses and cellulitis","volume":"15","author":"Meislin","year":"1986","journal-title":"Ann Emerg Med"},{"key":"2020110410211695100_ref158","first-page":"337","article-title":"Postoperative wound infection","volume-title":"Current therapy of infectious disease","author":"Dellinger","year":"1996"},{"key":"2020110410211695100_ref159","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-8588(18)30268-5","article-title":"Management of infection in patients with acute leukemia","volume":"7","author":"Wade","year":"1993","journal-title":"Hematol Oncol Clin North Am"},{"key":"2020110410211695100_ref160","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","article-title":"Management of fever in patients with cancer and treatment-induced neutropenia","volume":"328","author":"Pizzo","year":"1993","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref161","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0891-5520(05)70291-9","article-title":"Fever in the compromised host","volume":"10","author":"Donowitz","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"2020110410211695100_ref162","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00005792-198503000-00004","article-title":"Dermatologic manifestations of infections in immunocompromised patients","volume":"64","author":"Wolfson","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"2020110410211695100_ref163","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.me.34.020183.001225","article-title":"Dermatologic manifestations of infection in the compromised host","volume":"34","author":"Wolfson","year":"1983","journal-title":"Annu Rev Med"},{"key":"2020110410211695100_ref164","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref165","first-page":"197","article-title":"National Comprehensive Cancer Network","volume":"13","author":"NCCN practice guidelines for fever and neutropenia","year":"1999","journal-title":"Oncology (Williston Park)"},{"key":"2020110410211695100_ref166","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0891-5520(05)70164-1","article-title":"Dermatologic infections in the immunocompromised (non-HIV) host","volume":"15","author":"Lopez","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"2020110410211695100_ref167","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1097-0142(19870215)59:4<844::AID-CNCR2820590431>3.0.CO;2-U","article-title":"Differences between first and subsequent fevers during prolonged neutropenia","volume":"59","author":"Wingard","year":"1987","journal-title":"Cancer"},{"key":"2020110410211695100_ref168","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archinte.160.4.501","article-title":"Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes","volume":"160","author":"Chatzinikolaou","year":"2000","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref169","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0732-8893(98)00038-8","article-title":"Empiric therapy of bacterial infections in patients with severe neutropenia","volume":"31","author":"Glauser","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020110410211695100_ref170","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/clinids\/14.6.1201","article-title":"Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors","volume":"14","author":"Elting","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref171","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/163.5.951","article-title":"Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients","volume":"163","author":"European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group","year":"1991","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref172","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/clinids\/23.6.1234","article-title":"Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality","volume":"23","author":"Edmond","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref173","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-110-1-9","article-title":"Coagulase-negative staphylococcal bacteremia: mortality and hospital stay","volume":"110","author":"Martin","year":"1989","journal-title":"Ann Intern Med"},{"key":"2020110410211695100_ref174","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/515379","article-title":"Perspective: attributable mortality\u2014the promise of better antimicrobial therapy","volume":"178","author":"Wenzel","year":"1998","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"2020110410211695100_ref175","first-page":"136","article-title":"Bacterial resistance in the patient with neoplastic disease","volume":"4","author":"Brown","year":"1995","journal-title":"Infect Dis Clin Pract"},{"key":"2020110410211695100_ref176","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/318486","article-title":"Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study","volume":"32","author":"Rubinstein","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref177","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","article-title":"2000 Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel","volume":"18","author":"Ozer","year":"2000","journal-title":"J Clin Oncol"},{"key":"2020110410211695100_ref178","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1086\/376637","article-title":"Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy","volume":"37","author":"Cometta","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref179","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"2020110410211695100_ref180","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients","volume":"86","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1989","journal-title":"Am J Med"},{"key":"2020110410211695100_ref181","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref182","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref183","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/164.4.731","article-title":"Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation","volume":"164","author":"Goodrich","year":"1991","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref184","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America","volume":"30","author":"Rex","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref185","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-91-4-539","article-title":"Candida tropicalis: a major pathogen in immunocompromised patients","volume":"91","author":"Wingard","year":"1979","journal-title":"Ann Intern Med"},{"key":"2020110410211695100_ref186","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archinte.1978.03630280026013","article-title":"Fever, rash, and muscle tenderness: a distinctive clinical presentation of disseminated candidiasis","volume":"138","author":"Jarowski","year":"1978","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref187","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00005792-198607000-00005","article-title":"Trichosporonosis in patients with neoplastic disease","volume":"65","author":"Walsh","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"2020110410211695100_ref188","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"2020110410211695100_ref189","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref190","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref191","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/313918","article-title":"Significance of aspergillemia in patients with cancer: a 10-year study","volume":"31","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref192","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198710293171802","article-title":"Primary cutaneous aspergillosis associated with Hickman intravenous catheters","volume":"317","author":"Allo","year":"1987","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref193","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00006454-199308000-00009","article-title":"Invasive Aspergillus infections in a pediatric hospital: a ten-year review","volume":"12","author":"Walmsley","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410211695100_ref194","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM197811162992007","article-title":"Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment","volume":"299","author":"Gartenberg","year":"1978","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref195","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0022-3476(80)80550-6","article-title":"Nosocomical Rhizopus infection (zygomycosis) in children","volume":"96","author":"Dennis","year":"1980","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"2020110410211695100_ref196","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/clinids\/14.Supplement_1.S43","article-title":"Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review","volume":"14","author":"Anaissie","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref197","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0195-6701(97)90197-3","article-title":"Fungaemia due to Fusarium spp. in cancer patients","volume":"36","author":"Krcmery","year":"1997","journal-title":"J Hosp Infect"},{"key":"2020110410211695100_ref198","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V90.3.999","article-title":"Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management","volume":"90","author":"Boutati","year":"1997","journal-title":"Blood"},{"key":"2020110410211695100_ref199","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","article-title":"Current and emerging azole antifungal agents","volume":"12","author":"Sheehan","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"2020110410211695100_ref200","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","article-title":"Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation","volume":"175","author":"Wald","year":"1997","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref201","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref202","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","article-title":"Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America","volume":"30","author":"Stevens","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref203","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/375080","article-title":"Caspofungin","volume":"36","author":"Deresinski","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref204","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/313498","article-title":"Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis","volume":"29","author":"Wingard","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref205","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref206","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref207","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref208","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1200\/JCO.2000.18.12.2476","article-title":"Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients","volume":"18","author":"Cagnoni","year":"2000","journal-title":"J Clin Oncol"},{"key":"2020110410211695100_ref209","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1365-2133.1997.d01-1183.x","article-title":"Skin infection caused by Mycobacterium avium","volume":"136","author":"Ichiki","year":"1997","journal-title":"Br J Dermatol"},{"key":"2020110410211695100_ref211","first-page":"112","article-title":"Disseminated Mycobacterium avium-intracellulare infection appearing as a panniculitis","volume":"106","author":"Sanderson","year":"1982","journal-title":"Arch Pathol Lab Med"},{"key":"2020110410211695100_ref212","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/166.2.405","article-title":"Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin","volume":"166","author":"Wallace","year":"1992","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref213","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0002-9343(86)90634-0","article-title":"Disseminated atypical mycobacterial infection in patients with hairy cell leukemia","volume":"80","author":"Bennett","year":"1986","journal-title":"Am J Med"},{"key":"2020110410211695100_ref214","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinids\/19.2.263","article-title":"Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients","volume":"19","author":"Patel","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1083-8791(00)70012-7","article-title":"Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections","volume":"6","author":"Gaviria","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020110410211695100_ref216","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/clinids\/11.3.407","article-title":"Nocardial infection in patients with neoplastic disease","volume":"11","author":"Berkey","year":"1989","journal-title":"Rev Infect Dis"},{"key":"2020110410211695100_ref217","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/clinids\/3.3.492","article-title":"Nocardial infections in the immunocompromised host: a detailed study in a defined population","volume":"3","author":"Simpson","year":"1981","journal-title":"Rev Infect Dis"},{"key":"2020110410211695100_ref218","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archinte.1983.00350040101013","article-title":"Trimethoprim-sulfamethoxazole therapy for Nocardia infections","volume":"143","author":"Smego","year":"1983","journal-title":"Arch Intern Med"},{"key":"2020110410211695100_ref219","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/0190-9622(95)91544-3","article-title":"Cutaneous manifestations of disseminated cryptococcosis","volume":"32","author":"Dimino-Emme","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"2020110410211695100_ref220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/345956","article-title":"Primary cutaneous cryptococcosis: a distinct clinical entity","volume":"36","author":"Neuville","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref221","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/clinids\/14.3.666","article-title":"Cryptococcal disease presenting as cellulitis","volume":"14","author":"Anderson","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref222","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref223","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2133.1989.tb01356.x","article-title":"Cutaneous cryptococcosis: treatment with oral fluconazole","volume":"120","author":"Shuttleworth","year":"1989","journal-title":"Br J Dermatol"},{"key":"2020110410211695100_ref224","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0002-9610(79)90050-3","article-title":"Disseminated histoplasmosis in renal transplant recipients","volume":"137","author":"Davies","year":"1979","journal-title":"Am J Surg"},{"key":"2020110410211695100_ref225","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1086\/313752","article-title":"Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America","volume":"30","author":"Wheat","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020110410211695100_ref226","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/infdis\/152.6.1172","article-title":"Infection with varicella-zoster virus after marrow transplantation","volume":"152","author":"Locksley","year":"1985","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref227","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1172\/JCI109739","article-title":"Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma","volume":"65","author":"Arvin","year":"1980","journal-title":"J Clin Invest"},{"key":"2020110410211695100_ref228","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198306163082404","article-title":"Acyclovir halts progression of herpes zoster in immunocompromised patients","volume":"308","author":"Balfour","year":"1983","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref229","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/infdis\/142.3.338","article-title":"Infection with herpes simplex virus and cell-mediated immunity after marrow transplant","volume":"142","author":"Meyers","year":"1980","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","article-title":"Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group","volume":"123","author":"Tyring","year":"1995","journal-title":"Ann Intern Med"},{"key":"2020110410211695100_ref231","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/infdis\/174.3.470","article-title":"Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection","volume":"174","author":"Cowan","year":"1996","journal-title":"J Infect Dis"},{"key":"2020110410211695100_ref232","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198907063210102","article-title":"A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States","volume":"321","author":"Johnson","year":"1989","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref233","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199710163371601","article-title":"Herpes simplex virus type 2 in the United States, 1976 to 1994","volume":"337","author":"Fleming","year":"1997","journal-title":"N Engl J Med"},{"key":"2020110410211695100_ref234","first-page":"254","article-title":"Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections","volume":"7","author":"Balfour","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020110410211695100_ref235","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0190-9622(91)70134-N","article-title":"Diagnosis of cutaneous cytomegalovirus infection: a review and report of a case","volume":"24","author":"Toome","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"2020110410211695100_ref236","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/320001","article-title":"Guidelines for the management of intravascular catheter-related infections","volume":"32","author":"Mermel","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/41\/10\/1373\/34126296\/41-10-1373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/41\/10\/1373\/34126296\/41-10-1373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T18:10:16Z","timestamp":1626631816000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/41\/10\/1373\/345303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":236,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2005,11,15]]},"published-print":{"date-parts":[[2005,11,15]]}},"URL":"https:\/\/doi.org\/10.1086\/497143","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11,15]]},"published":{"date-parts":[[2005,11,15]]}}}